STOCK TITAN

Hims & Hers CFO sells 12,313 shares at $28.82

The Hims & Hers CFO reported a Rule 10b5-1 planned sale of 12,313 shares, retaining over 250,000 shares directly plus additional indirect holdings.

(High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) reported that its Chief Financial Officer, Oluyemi Okupe, sold 12,313 shares of Class A Common Stock on September 17, 2026 at $28.82 per share in an open-market transaction pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on May 20, 2026. Following this sale, he directly held 251,804 shares and indirectly held 7,853 shares through a separate property trust.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Okupe Oluyemi
Role Chief Financial Officer
Sold 12,313 shs ($355K)
Type Security Shares Price Value
Sale Class A Common Stock F1 12,313 $28.82 $355K
holding Class A Common Stock -- -- --
Holdings After Transaction: Class A Common Stock — 251,804 shares (Direct); Class A Common Stock — 7,853 shares (Indirect, Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021)
Footnotes (1)
  1. F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.
Shares sold 12,313 shares Class A Common Stock sold by the CFO on September 17, 2026
Sale price per share $28.82 per share Price for the 12,313 shares sold on September 17, 2026
Direct holdings after transaction 251,804 shares Class A Common Stock directly owned by the CFO after the sale
Indirect holdings after transaction 7,853 shares Class A Common Stock held by the Oluyemi Okupe Separate Property Trust
Net shares sold 12,313 shares Net change in reported non-derivative holdings from this Form 4
Rule 10b5-1 trading plan regulatory
"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
separate property trust financial
"Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021"
indirectly held financial
"Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HIMS report for CFO Oluyemi Okupe?

The CFO, Oluyemi Okupe, sold 12,313 shares of Hims & Hers Class A Common Stock on September 17, 2026 at a price of $28.82 per share in an open-market transaction under a Rule 10b5-1 trading plan.

How many HIMS shares does the CFO hold after this reported sale?

After the sale, the CFO directly held 251,804 shares of Hims & Hers Class A Common Stock and indirectly held 7,853 shares through a separate property trust, as reported in the Form 4.

Was the HIMS CFO’s September 17, 2026 share sale under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the reporting person, indicating the trades were pre-arranged under that plan.

What price did the HIMS CFO receive for the shares sold?

The CFO’s reported sale of Hims & Hers Class A Common Stock on September 17, 2026 was at a price of $28.82 per share, with 12,313 shares sold in that transaction.

How many HIMS shares are held indirectly for the CFO?

The Form 4 reports that 7,853 shares of Hims & Hers Class A Common Stock are held indirectly for the CFO by the “Oluyemi Okupe Separate Property Trust dtd 9-1-2021.”

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Okupe Oluyemi

(Last)(First)(Middle)
2269 CHESTNUT STREET, #523

(Street)
SAN FRANCISCO CALIFORNIA 94123

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock09/17/2026S(1)12,313D$28.82251,804D
Class A Common Stock7,853IHeld by Oluyemi Okupe Separate Property Trust dtd 9-1-2021
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.
Remarks:
/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe09/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading